Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioventus (BVS) Leases (2020 - 2025)

Bioventus (BVS) has disclosed Leases for 6 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 28.7% year-over-year to $11.2 million, compared with a TTM value of $11.2 million through Dec 2025, down 28.7%, and an annual FY2025 reading of $11.2 million, down 28.7% over the prior year.
  • Leases was $11.2 million for Q4 2025 at Bioventus, down from $11.6 million in the prior quarter.
  • Across five years, Leases topped out at $18.7 million in Q2 2022 and bottomed at $128000.0 in Q4 2022.
  • Average Leases over 5 years is $14.2 million, with a median of $15.5 million recorded in 2023.
  • The sharpest move saw Leases tumbled 99.26% in 2022, then surged 11055.47% in 2023.
  • Year by year, Leases stood at $17.2 million in 2021, then crashed by 99.26% to $128000.0 in 2022, then soared by 11055.47% to $14.3 million in 2023, then increased by 10.21% to $15.7 million in 2024, then decreased by 28.7% to $11.2 million in 2025.
  • Business Quant data shows Leases for BVS at $11.2 million in Q4 2025, $11.6 million in Q3 2025, and $12.0 million in Q2 2025.